Oncolysis is greatly enhanced by retargeting of replication-selective adenoviral mutants to av beta 6-integrin expressing cancers and in combination with cytotoxic drugs

Man Y. K. Stella; Coughlan Lynda; Pantelidou Constantia; Hallden Gunnel

首页> 外文期刊>Human gene therapy >Oncolysis is greatly enhanced by retargeting of replication-selective adenoviral mutants to av beta 6-integrin expressing cancers and in combination with cytotoxic drugs

【24h】

Oncolysis is greatly enhanced by retargeting of replication-selective adenoviral mutants to av beta 6-integrin expressing cancers and in combination with cytotoxic drugs

机译：通过将复制选择性腺病毒突变体重新靶向表达av beta 6整合素的癌症并与细胞毒性药物联合使用，可以大大增强溶瘤作用

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Human gene therapy》 |2014年第12期|共1页
作者
Man Y. K. Stella; Coughlan Lynda; Pantelidou Constantia; Hallden Gunnel;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Oncolysis is greatly enhanced by retargeting of replication-selective adenoviral mutants to av beta 6-integrin expressing cancers and in combination with cytotoxic drugs [J] . Man Y. K. Stella, Coughlan Lynda, Pantelidou Constantia, Human gene therapy . 2014,第12期

机译：通过将复制选择性腺病毒突变体重新靶向表达av beta 6整合素的癌症并与细胞毒性药物联合使用，可以大大增强溶瘤作用
2. The Novel Oncolytic Adenoviral Mutant Ad5-3 Delta-A20T Retargeted to alpha v beta 6 Integrins Efficiently Eliminates Pancreatic Cancer Cells [J] . Man Y. K. Stella, Davies James A., Coughlan Lynda, Molecular cancer therapeutics . 2018,第2期

机译：新型溶血性腺病毒突变体AD5-3δ-A20T术语αVβ6整合蛋白有效消除胰腺癌细胞
3. A transductionally retargeted adenoviral vector for virotherapy of her2eu-expressing prostate cancer [J] . MagnussonM.K., KraaijR., LeadleyR.M., Human gene therapy . 2012,第1期

机译：转导靶向腺病毒载体，用于病毒治疗表达her2 / neu的前列腺癌
4. Enhancement of Effects of Chitosan and Nanoparticles on Pancreatic Cancer Cells by Combination Treatments with the Anti-Cancer Drug Adriamycin [C] . J.C.K.Lai, W.Gao, A.Bhushan TechConnect World Innovation Conference Expo;Annual SBIR/STTR Spring Innovation Conference;Annual Nanotech Conference Expo;AI TechConnect Spring Conference Expo . 2019

机译：用抗癌药物亚霉素组合治疗提高壳聚糖和纳米粒子对胰腺癌细胞的影响
5. Multimodal Therapeutic Strategy for Pancreatic Cancer: EGFR-Targeted Gelatin-Based Nanoparticles for Combination Wild-Type p53 Gene and Cytotoxic Drug Delivery. [D] . Xu, Jing. 2013

机译：胰腺癌的多模式治疗策略：结合野生型p53基因和细胞毒性药物递送的EGFR靶向明胶纳米颗粒。
6. A Transductionally Retargeted Adenoviral Vector for Virotherapy of Her2eu-Expressing Prostate Cancer [O] . M.K. Magnusson, R. Kraaij, R.M. Leadley, -1

机译：转导靶向腺病毒载体的病毒治疗Her2 / neu表达的前列腺癌。
7. 801. Targeting of Prostate Cancer Cells with the Novel Replication-Selective Adenoviral Mutant Adδδ in Combination with the Phytochemical Drugs Eqoul and Resveratrol [O] . 2011

机译：801.将前列腺癌细胞与新型复制选择性腺病毒突变体Adδδ联合靶向植物化学药物的Eqoul和白藜芦醇
8. In Vivo shRNA-Drug Screen to Identify Novel Targeted Therapy Combinations for KRAS Mutant Cancers. [R] . Corcoran, R. B. 2014

机译：在体内shRNa-药物筛选中鉴定用于KRas突变癌症的新型靶向治疗组合。

Oncolysis is greatly enhanced by retargeting of replication-selective adenoviral mutants to av beta 6-integrin expressing cancers and in combination with cytotoxic drugs

著录项

相似文献

相关主题

期刊订阅